Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000658779 | SCV000780574 | benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | STAT3: PP2, BS1, BS2 |
Centre for Mendelian Genomics, |
RCV001198591 | SCV001369581 | uncertain significance | STAT3-related early-onset multisystem autoimmune disease | 2019-10-27 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: No criteria apply. |
Labcorp Genetics |
RCV001433648 | SCV001636439 | likely benign | Hyper-IgE recurrent infection syndrome 1, autosomal dominant; STAT3 gain of function | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001816659 | SCV002071267 | uncertain significance | not specified | 2019-10-11 | criteria provided, single submitter | clinical testing |